PRCT Insider Trading
Insider Ownership Percentage: 17.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $62,839,018.02
PROCEPT BioRobotics Insider Trading History Chart
This chart shows the insider buying and selling history at PROCEPT BioRobotics by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
PROCEPT BioRobotics Share Price & Price History
Current Price: $62.33
Price Change: ▼ Price Decrease of -0.2 (-0.32%)
As of 03/26/2025 05:00 PM ET
PROCEPT BioRobotics Insider Trading History
SEC Filings (Institutional Ownership Changes) for PROCEPT BioRobotics (NASDAQ:PRCT)
89.46% of PROCEPT BioRobotics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
This chart shows the instiutional buying and selling at PRCT by year and by quarter.
Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
PROCEPT BioRobotics Institutional Trading History
Data available starting January 2016
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Read More on PROCEPT BioRobotics
Today's Range
Now: $62.33
52 Week Range
Now: $62.33
Volume
1,150,523 shs
Average Volume
734,787 shs
Market Capitalization
$3.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.05
Who are the company insiders with the largest holdings of PROCEPT BioRobotics?
Who are the major institutional investors of PROCEPT BioRobotics?
Which major investors are selling PROCEPT BioRobotics stock?
During the previous quarter, PRCT stock was sold by these institutional investors:
- JPMorgan Chase & Co.
- Champlain Investment Partners LLC
- Bellevue Group AG
- Lord Abbett & CO. LLC
- Nuveen Asset Management LLC
- Price T Rowe Associates Inc. MD
- Osterweis Capital Management Inc.
- T. Rowe Price Investment Management Inc.
In the last year, company insiders that have sold PROCEPT BioRobotics company stock include:
- Frederic H Moll (Director)
- Antal Rohit Desai (Director)
- Reza Zadno (CEO)
- Morgan Colby Wood (Director)
- Kevin Waters (CFO)
- Hisham Shiblaq (EVP)
Learn More investors selling PROCEPT BioRobotics stock.
Which major investors are buying PROCEPT BioRobotics stock?
During the last quarter, PRCT stock was bought by institutional investors including:
- FMR LLC
- Perpetual Ltd
- Wellington Management Group LLP
- Vanguard Group Inc.
- Renaissance Technologies LLC
- Allspring Global Investments Holdings LLC
- Invesco Ltd.
- Frontier Capital Management Co. LLC